Search
for
Sort by
Research 61–90 of 90
- Survey on adverse events associated with drug therapy for breast cancer patients
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- The association of medications and supplements with human male reproductive health: a systematic review
- Molecular Engineering of Recombinant Protein Hydrogels: Programmable Design and Biomedical Applications
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Medical Dermatology
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Pharmaceutical care in transplantation: current challenges and future opportunities
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Vitiligo and Its Mimics in Childhood: A Diagnostic Framework for Hypopigmented Disorders
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- A systematic review on Drug Re-profiling/Re-Purposing
- CAQ Corner: Basic concepts of transplant immunology
- Dermatological Complications in Transplant Patients and Composite Tissue Allotransplant Pathology
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- Forum
- Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study